| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008091620A2 Combination therapy comprising romidepsin and i.a. bortezomib |
| 07/31/2008 | WO2008091064A1 Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090901A1 Chronic rejection inhibitor |
| 07/31/2008 | WO2008090850A1 Agent for enhancing the effect of anticancer agent |
| 07/31/2008 | WO2008090334A1 Serotonin receptor antagonists for treating arthritis |
| 07/31/2008 | WO2008090331A1 Serotonin reuptake inhibitors for treating arthritis |
| 07/31/2008 | WO2008090327A1 New combination for use in the treatment of cancer |
| 07/31/2008 | WO2008089659A1 The use of dopamine transporters and noradrenaline transporters dual inhibitors |
| 07/31/2008 | WO2008068621A3 Combination product with ido inhibitor and tumor targeted ifn-gamma |
| 07/31/2008 | WO2008065409A3 Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor |
| 07/31/2008 | WO2008020085A3 Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy |
| 07/31/2008 | WO2008016793A3 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 07/31/2008 | WO2007149283B1 Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| 07/31/2008 | WO2007136892A3 Engineered antibody-stress protein fusions |
| 07/31/2008 | WO2007109244A3 Novel nanoparticles for delivery of active agents |
| 07/31/2008 | WO2006138571A3 Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance |
| 07/31/2008 | US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182867 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/31/2008 | US20080182814 Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia |
| 07/31/2008 | US20080181900 Vascular Endothelial Cell Growth Factor Antagonists |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | DE102007004938A1 Medicament for avoiding or alleviating large clostridial cytotoxins, comprises an effector, which is an inhibitor or activator of the protease activity of large clostridial cytotoxins |
| 07/31/2008 | DE102004039196B4 Neue Formulierung für L-Tryptophan New formulation of L-tryptophan |
| 07/31/2008 | CA2676387A1 Combination therapy |
| 07/31/2008 | CA2675625A1 Chronic rejection inhibitor |
| 07/30/2008 | EP1950294A1 Novel cell penetrating peptide |
| 07/30/2008 | EP1950293A1 Method for prediction of effectiveness of rar- agonist |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949909A1 Use of Botulinum Toxin Therapy for Treatment of Urge Type Dysfunction |
| 07/30/2008 | EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 07/30/2008 | EP1949906A1 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 07/30/2008 | EP1949902A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 07/30/2008 | EP1949895A1 Iontophoresis preparation |
| 07/30/2008 | EP1949894A2 Enhancement of vanadium-containing phosphatase inhibitors by polyols |
| 07/30/2008 | EP1948238A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 07/30/2008 | EP1948237A1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 07/30/2008 | EP1948236A2 Methods and compositions for treatment of skin |
| 07/30/2008 | EP1948195A2 Improved methods of using phosphoantigen for the treatment of cancer |
| 07/30/2008 | EP1948150A2 Combinations of metformin and meglitinide |
| 07/30/2008 | EP1948138A1 Segmented pharmaceutical dosage forms |
| 07/30/2008 | EP1791535B1 Novel tellurium compounds and their use as immunomodulators |
| 07/30/2008 | EP1653943B3 Catechol derivatives for the treatment of cancer |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1480646B1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 07/30/2008 | EP1328269B2 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 07/30/2008 | EP1041977B1 Use of ppar-gamma activators for treating dermatological disorders |
| 07/30/2008 | EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 07/30/2008 | CN101232897A Angiogenetic agent containing adrenomedulin as the active ingredient |
| 07/30/2008 | CN101232894A Anticancer agent to be combined with telomelysin |
| 07/30/2008 | CN101232822A Composition for reducing the risc of ethanol metabolism and alcohol induced neuropathy |
| 07/30/2008 | CN101230100A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/30/2008 | CN101229380A Targeted delivery of drugs for the treatment of viral infections |
| 07/30/2008 | CN101229376A Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/30/2008 | CN101229375A Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/30/2008 | CN101229374A Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/30/2008 | CN101229373A Medicine compounds for treating diabetic nephropathy |
| 07/30/2008 | CN101229372A Medicine compounds for treating hypertension |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229178A Compound medicine compounds containing adefovir dipivoxil, preparing method and uses thereof |
| 07/30/2008 | CN101229173A Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 07/30/2008 | CN101229164A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 07/30/2008 | CN101229156A Medicine compounds used for cardiovascular disorders |
| 07/30/2008 | CN101229118A Thermostatic sustained release injection containing topoisomerase inhibitor and preparing method thereof |
| 07/30/2008 | CN101229117A Thermostatic sustained release injection containing phosphatidylinositol 3-genistein inhibitor and preparing method thereof |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406427C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 07/30/2008 | CN100406064C Formulation for treating disease infected by helicobacter pylori |
| 07/30/2008 | CN100406063C External-applied ointment used for treating thyropathy, and its preparing method |
| 07/30/2008 | CN100406017C Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405192 Difference between the amplified sequence and the normal gene sequence is diagnostic of glaucoma |
| 07/29/2008 | US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay |
| 07/29/2008 | US7405045 Retrieving ductal fluid samples from ducts using elongated lumen and detecting presence of papilloma, Epstein-barr and herpes virus |
| 07/29/2008 | US7404973 For use as dietary supplement, in drugs, soy protein concentrate |
| 07/29/2008 | US7404968 unit aliquot dose of a pharmaceutical electricstatically deposited on a porous, permeable or semi-permeable ingestible membrane; including two or more active pharmaceuticals segregated from one another in a single delivery package. |
| 07/29/2008 | US7404965 Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2401952C Pyranoindoles for treating glaucoma |
| 07/29/2008 | CA2381729C Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
| 07/29/2008 | CA2367214C Method for a programmed controlled ovarian stimulation protocol |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |